Comparing bone marrow in patients with follicular lymphoma and healthy controls

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective single-center study aims to investigate the differences in cell composition between the bone marrow of patients diagnosed with follicular lymphoma and that of healthy control subjects. By utilizing samples obtained during surgeries involving sternotomies, the study will establish a bone marrow bank for patients without hematological diseases, which will serve as a control cohort for future clinical trials. The research seeks to enhance understanding of the microenvironment in the bone marrow that may contribute to the relapses seen in follicular lymphoma patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Major patient
* Patient hospitalized in the thoracic, cardiac and vascular surgery department for surgery involving a sternotomy
* Patient with free, informed, written consent
* Patient covered by a health insurance scheme

Exclusion Criteria:

* History of haematological malignancy or haemogram disturbance
* Immunomodulating treatment: immunosuppressants, corticoids, antineoplastics
* Persons covered by articles L. 1121-5 to L. 1121-8 and L. 1122-1-2 of the French Public Health Code (e.g. minors, protected adults, etc.)\].

Where it's running

• CHU Rennes
  Rennes, France Recruiting

Study contacts

• Study coordinator: Juliette Ferrant, MD
• Email: juliette.ferrant@chu-rennes.fr
• Phone: 0299282555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• MK-1045 for follicular lymphoma and diffuse large B-cell lymphoma

  This trial tests MK-1045 in people with follicular lymphoma or diffuse large B-cell lymphoma to see if the treatment is safe and tolerable and whether the cancer shrinks or disappears.

  Recruiting at 54 sites Phase 1/2 Merck Sharp & Dohme LLC · Los Angeles, California and 53 other locations · NCT07519772

• New therapy dose test for people with prior B-cell cancers

  This early-phase study tests different doses of LY4152199 to see if it is safe and effective for people who have already been treated for certain B-cell lymphomas.

  Recruiting at 25 sites Phase 1 Eli Lilly and Company · Duarte, California and 50 other locations · NCT07101328

• CAR T Cell Therapy for Resistant B-cell Cancers

  This study is testing a new CAR T cell therapy to see if it can safely help people with tough-to-treat B-cell cancers like leukemia and lymphoma.

  Recruiting Phase 1/2 Essen Biotech · Beijing, Beijing Municipality · NCT06213636

• Treatment of B-cell malignancies with ALETA-001

  This study is testing a new treatment called ALETA-001 to see if it can help people with relapsed non-Hodgkin lymphoma who didn't respond well to previous therapies.

  Recruiting at 6 sites Phase 1/2 Cancer Research UK · Birmingham and 6 other locations · NCT06045910

• Treatment of early relapse follicular lymphoma with mosunetuzumab

  This study is testing if a new treatment called mosunetuzumab can help adults with follicular lymphoma who have had a relapse within two years feel better and live longer compared to standard treatments.

  Recruiting at 3 sites Phase 2 Oslo University Hospital · Helsinki and 2 other locations · NCT05849857

• Long-term Fertility After Lymphoma Treatment in Young Women

  This observational study follows young women who had lymphoma and chemotherapy to see how their ovarian reserve changes years after treatment.

  Recruiting University Hospital, Lille · Lille · NCT05616325

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.